The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications
Open accessAbstract
Pharmaceutical cocrystals are multicomponent systems in which at least one component is an active pharmaceutical ingredient and the others are pharmaceutically acceptable ingredients. Cocrystallization of a drug substance with a coformer is a promising and emerging approach to improve the performance of pharmaceuticals, such as solubility, dissolution profile, pharmacokinetics and stability. This review article presents a comprehensive overview of pharmaceutical cocrystals, including preparation methods, physicochemical properties, and applications. Furthermore, some examples of drug cocrystals are highlighted to illustrate the effect of crystal structures on the various aspects of active pharmaceutical ingredients, such as physical stability, chemical stability, mechanical properties, optical properties, bioavailability, sustained release and therapeutic effect. This review will provide guidance for more efficient design and manufacture of pharmaceutical cocrystals with desired physicochemical properties and applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insoluble drug delivery strategies: review of recent advances and business prospects
Kalepu, S., & Nekkanti, V. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.07.003 · Cited by 1,410
Pharmaceutical cocrystals: along the path to improved medicines
Duggirala, N. K., Perry, M. L., Almarsson, Ö., & Zaworotko, M. J. (2016) · Chemical Communications · doi:10.1039/c5cc08216a · Cited by 928
Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications
Karimi-Jafari, M., Padrela, L., Walker, G. M., & Croker, D. M. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b00933 · Cited by 667
Crystal structures of drugs: advances in determination, prediction and engineering
Datta, S., & Grant, D. J. W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1280 · Cited by 583
Designed biomaterials to mimic the mechanical properties of muscles
Lv, S., Dudek, D. M., Cao, Y., Balamurali, M. M., Gosline, J., & Li, H. (2010) · Nature · doi:10.1038/nature09024 · Cited by 562
Yan, D., Delori, A., Lloyd, G. O., Friščić, T., Day, G. M., Jones, W., Lu, J., Wei, M., Evans, D. G., & Duan, X. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201106391 · Cited by 534
Trends in Solubility of Polymorphs
Pudipeddi, M., & Serajuddin, A. T. M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20302 · Cited by 505
Khankari, R. K., & Grant, D. J. W. (1995) · Thermochimica Acta · doi:10.1016/0040-6031(94)01952-d · Cited by 485
Yan, D., & Evans, D. G. (2014) · Mater. Horiz. · doi:10.1039/c3mh00023k · Cited by 484
Weyna, D. R., Shattock, T., Vishweshwar, P., & Zaworotko, M. J. (2009) · Crystal Growth & Design · doi:10.1021/cg800936d · Cited by 445
Cocrystals of Quercetin with Improved Solubility and Oral Bioavailability
Smith, A. J., Kavuru, P., Wojtas, L., Zaworotko, M. J., & Shytle, R. D. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200209j · Cited by 390
Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals
Healy, A. M., Worku, Z. A., Kumar, D., & Madi, A. M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.002 · Cited by 370
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges
Cerreia Vioglio, P., Chierotti, M. R., & Gobetto, R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.001 · Cited by 350
Pharmaceutical cocrystals: from serendipity to design to application
Kavanagh, O. N., Croker, D. M., Walker, G. M., & Zaworotko, M. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.023 · Cited by 323
Epalrestat: An Aldose Reductase Inhibitor for the Treatment of Diabetic Neuropathy
Ramirez, M. A., & Borja, N. L. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.5.646 · Cited by 303
Lien Nguyen, K., Friščić, T., Day, G. M., Gladden, L. F., & Jones, W. (2007) · Nature Materials · doi:10.1038/nmat1848 · Cited by 289
Exploration of biocompatible AIEgens from natural resources
Gu, Y., Zhao, Z., Su, H., Zhang, P., Liu, J., Niu, G., Li, S., Wang, Z., Kwok, R. T. K., Ni, X.-L., et al. (2018) · Chemical Science · doi:10.1039/c8sc01635f · Cited by 262
Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients
Vishweshwar, P., McMahon, J. A., Peterson, M. L., Hickey, M. B., Shattock, T. R., & Zaworotko, M. J. (2005) · Chemical Communications · doi:10.1039/b501304f · Cited by 244
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5
Kuminek, G., Cao, F., Bahia de Oliveira da Rocha, A., Gonçalves Cardoso, S., & Rodríguez-Hornedo, N. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.022 · Cited by 230
Chow, S. F., Chen, M., Shi, L., Chow, A. H. L., & Sun, C. C. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0709-5 · Cited by 193
Pharmaceutical Cocrystals: Molecules, Crystals, Formulations, Medicines
Yousef, M. A. E., & Vangala, V. R. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01898 · Cited by 169
How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine
Chadwick, K., Davey, R. J., & Cross, W. I. (2007) · CrystEngComm · doi:10.1039/b709411f · Cited by 156
Co-crystals give light a tune-up
Wuest, J. D. (2012) · Nature Chemistry · doi:10.1038/nchem.1256 · Cited by 150
Co‐crystal Prediction by Artificial Neural Networks**
Devogelaer, J., Meekes, H., Tinnemans, P., Vlieg, E., & Gelder, R. D. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009467 · Cited by 147
Baicalein–Nicotinamide Cocrystal with Enhanced Solubility, Dissolution, and Oral Bioavailability
Huang, Y., Zhang, B., Gao, Y., Zhang, J., & Shi, L. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24048 · Cited by 144
Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability
Zhu, B., Zhang, Q., Wang, J., & Mei, X. (2017) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b01863 · Cited by 138
Improving the Membrane Permeability of 5-Fluorouracil via Cocrystallization
Dai, X.-L., Li, S., Chen, J., & Lu, T. (2016) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b00552 · Cited by 108
Self-citationJubeen, F., Liaqat, A., Amjad, F., Sultan, M., Iqbal, S. Z., Sajid, I., Niazi, M. B. K., & Sher, F. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.9b01570 · Cited by 105
Wang, C., Tong, Q., Hou, X., Hu, S., Fang, J., & Sun, C. C. (2016) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b00591 · Cited by 100
Cocrystals of Hesperetin: Structural, Pharmacokinetic, and Pharmacodynamic Evaluation
Chadha, K., Karan, M., Bhalla, Y., Chadha, R., Khullar, S., Mandal, S. K., & Vasisht, K. (2017) · Crystal Growth & Design · doi:10.1021/acs.cgd.6b01769 · Cited by 96
Shinozaki, T., Ono, M., Higashi, K., & Moribe, K. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.02.014 · Cited by 92
Prodrugs - An Efficient Way to Breach Delivery and Targeting Barriers
Huttunen, K. M., & Rautio, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611797183230 · Cited by 86
Physical Stability Enhancement and Pharmacokinetics of a Lithium Ionic Cocrystal with Glucose
Duggirala, N. K., Smith, A. J., Wojtas, Ł., Shytle, R. D., & Zaworotko, M. J. (2014) · Crystal Growth & Design · doi:10.1021/cg501310d · Cited by 86
Steele, J., Faulds, D. M., & Goa, K. L. (1993) · Drugs & Aging · doi:10.2165/00002512-199303060-00007 · Cited by 84
Structural and Physicochemical Aspects of Dasatinib Hydrate and Anhydrate Phases
Roy, S., Quiñones, R., & Matzger, A. J. (2012) · Crystal Growth & Design · doi:10.1021/cg300152p · Cited by 82
Nguyen, H. N., Ha, P. T., Nguyen, A. S., Nguyen, D. T., Do, H. D., Quy, N. T., & Thi, M. N. H. (2016) · Advances in Natural Sciences Nanoscience and Nanotechnology · doi:10.1088/2043-6262/7/2/025001 · Cited by 78
Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin
Deng, J.-H., Lu, T., Sun, C. C., & Chen, J. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.04.008 · Cited by 75
Self-citationSun, G., Jin, Y., Li, S., Yang, Z., Shi, B., Chang, C., & Abramov, Y. A. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02371 · Cited by 75
Novel Synthons in Sulfamethizole Cocrystals: Structure–Property Relations and Solubility
Suresh, K., Minkov, V. S., Namila, K. K., Derevyannikova, E. A., Losev, E. A., Nangia, A. K., & Boldyreva, E. V. (2015) · Crystal Growth & Design · doi:10.1021/acs.cgd.5b00587 · Cited by 70
Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation
Mannava, M. K. C., Gunnam, A., Lodagekar, A., Shastri, N. R., Nangia, A. K., & Solomon, K. A. (2020) · CrystEngComm · doi:10.1039/d0ce01316a · Cited by 67
Enhancing biopharmaceutical parameters of bioflavonoid quercetin by cocrystallization
Vasisht, K., Chadha, K., Karan, M., Bhalla, Y., Jena, A. K., & Chadha, R. (2016) · CrystEngComm · doi:10.1039/c5ce01899d · Cited by 63
Cocrystal formation by ionic liquid-assisted grinding: case study with cocrystals of caffeine
Mukherjee, A., Rogers, R. D., & Myerson, A. S. (2018) · CrystEngComm · doi:10.1039/c8ce00859k · Cited by 62
Drug–drug co-crystallization presents a new opportunity for the development of stable vitamins
Wang, J., Yu, Q., Dai, W., & Mei, X. (2016) · Chemical Communications · doi:10.1039/c5cc10297a · Cited by 61
Li, P., Ramaiah, T., Zhang, M., Zhang, Y., Huang, Y., & Lou, B. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.9b00939 · Cited by 60
Mechanical Properties of Anhydrous and Hydrated Uric Acid Crystals
Liu, F., Hooks, D. E., Li, N., Mara, N. A., & Swift, J. A. (2018) · Chemistry of Materials · doi:10.1021/acs.chemmater.8b00939 · Cited by 58
Extended Release of Highly Water Soluble Isoniazid Attained through Cocrystallization with Curcumin
Xuan, B., Wong, S. N., Zhang, Y., Weng, J., Tong, H. H. Y., Wang, C., Sun, C. C., & Chow, S. F. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.9b01619 · Cited by 57
Serrano, D. R., Persoons, T., D'Arcy, D. M., Galiana, C., Dea‐Ayuela, M. A., & Healy, A. M. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.04.030 · Cited by 55
Evaluation of the formation pathways of cocrystal polymorphs in liquid-assisted syntheses
Fischer, F., Scholz, G., Benemann, S., Rademann, K., & Emmerling, F. (2014) · CrystEngComm · doi:10.1039/c4ce00472h · Cited by 54
Anisotropic elasticity and plasticity of an organic crystal
Wang, J., Li, M., Yu, Q., Zhang, Z., Zhu, B., Qin, W., & Mei, X. (2019) · Chemical Communications · doi:10.1039/c9cc03542g · Cited by 54
Ketoconazole-p-aminobenzoic Acid Cocrystal: Revival of an Old Drug by Crystal Engineering
Martin, F., Pop, M. M., Kacsó, I., Grosu, I., Miclaus, M. O., Vodnar, D. C., Lung, I., Filip, G. A., Olteanu, D. E., Moldovan, R., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01178 · Cited by 54
Yadav, B., Sridhar, B., Chavan, R. B., Thipparaboina, R., Naidu, V. G. M., & Shastri, N. R. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.7b01514 · Cited by 52
Enhancing the Pharmaceutical Properties of Pirfenidone by Mechanochemical Cocrystallization
Kumari, N., Bhattacharya, B., Roy, P. S., Michalchuk∞, A. A. L., Emmerling, F., & Ghosh, A. (2019) · Crystal Growth & Design · doi:10.1021/acs.cgd.9b00932 · Cited by 52
Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters
Gautam, M. K., Besan, M., Pandit, D., Mandal, S. K., & Chadha, R. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1360-9 · Cited by 51
Wang, L., Bu, F.-Z., Li, Y., Wu, Z., & Yan, C. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00075 · Cited by 51
Structural Basis for Mechanical Anisotropy in Polymorphs of a Caffeine–Glutaric Acid Cocrystal
Mishra, M. K., Mishra, K., Narayan, A., Reddy, C. M., & Vangala, V. R. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c01033 · Cited by 50
Deng, Y., Zhang, Y., Huang, Y., Zhang, M., & Lou, B. (2018) · Crystal Growth & Design · doi:10.1021/acs.cgd.8b01257 · Cited by 49
Shemchuk, O., D’Agostino, S., Fiore, C., Sambri, V., Zannoli, S., Grepioni, F., & Braga, D. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00900 · Cited by 46
Videla, S., Lahjou, M., Vaqué, A., Sust, M., Encabo, M., Soler, L., Sans, A., Sicard, É., Gascón, N., Encina, G., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13395 · Cited by 45
Cocrystals of quercetin: synthesis, characterization, and screening of biological activity
Veverka, M., Dubaj, T., Gallovič, J., Jorı́k, V., Veverková, E., Danihelová, M., & Šimon, P. (2014) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-014-1314-6 · Cited by 42
Abosede, O. O., Gordon, A. T., Dembaremba, T. O., Lorentino, C. M. A., Frota, H. F., dos Santos, A. L. S., Hosten, E. C., & Ogunlaja, A. S. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00301 · Cited by 41
Putra, O. D., Umeda, D., Nugraha, Y. P., Nango, K., Yonemochi, E., & Uekusa, H. (2017) · Crystal Growth & Design · doi:10.1021/acs.cgd.7b01371 · Cited by 40
Zhou, J., Li, L., Zhang, H., et al. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118984 · Cited by 40
Kumar, S. S., Athimoolam, S., & Sridhar, B. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.07.079 · Cited by 37
Wang, L., Wang, L., Yu, Y., Li, Y., Wu, Z., & Yan, C. (2020) · CrystEngComm · doi:10.1039/d0ce00713g · Cited by 34
Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
Arafa, M. F., El‐Gizawy, S. A., Osman, M. A., & Maghraby, G. M. E. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.01.005 · Cited by 32
Exploring potential coformers for oxyresveratrol using principal component analysis
Ouiyangkul, P., Tantishaiyakul, V., & Hirun, N. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119630 · Cited by 30
Strategy for Efficient Discovery of Cocrystals via a Network-Based Recommendation Model
Zheng, L., Zhu, B., Wu, Z., Fang, X., Hong, M., Liu, G., Li, W., Ren, G., & Tang, Y. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00911 · Cited by 25
Cha, D. S., Luo, X., Ahmed, J., Becirovic, L., Cha, R. H., & McIntyre, R. S. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1653759 · Cited by 13
Somphon, W., Prasertsabw, A., & Jarussophon, N. (2019) · Materials Today Proceedings · doi:10.1016/j.matpr.2019.06.227 · Cited by 7
Cited by
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Metadata
- Authors
- Guo, M., Sun, X., Chen, J., & Cai, T.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 11
- Issue
- 8
- Pages
- 2537-2564
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W3137880689
- Cited by
- 386
- References
- 69
- FWCI
- 27.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.